Jane Sugarman

Dados Biográficos

ID227173
NOMEJane Sugarman
PRENOMESJane
SOBRENOMESugarman
ASSINATURASUGARMAN J
AFILIAÇÕESJohns Hopkins University
ORCID0000-0001-7022-8332
VERIFICADOSim
TOTAL DE OBRAS51
TOTAL DE CITAÇÕES33
TOTAL COMO AUTOR51
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO1985
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H3

  • Impact of Legal Perceptions and Disclosure on Willingness to Undergo HIV Antiretroviral Resistance Testing Among Men Who Have Sex with Men

    Open AccessCoralei E Neighbors, Thomas Sanchez et al.ARTICLEAIDS and Behavior2026

  • Enhancing Research Ethics Capacity in Asia

    Open AccessNeena Gopalan, Robyna Irshad Khan et al.ARTICLEJournal of Empirical Research on…2025Referências: 2

    Several Asian countries, including India, Malaysia, Myanmar, and Pakistan, face challenges aligning rapid healthcare and biomedical research growth with necessary ethics oversight. To help address this, the Fogarty International Center of the United States National Institutes of Health funded initiatives to enhance research ethics capacities in these countries. In India, the Yenepoya University's Master's in Research Ethics program was establishe…

  • Defining Malaysia's health research ethics system through a stakeholder driven approach

    Open AccessSean Tackett, Chirk Jenn Ng et al.ARTICLEDeveloping World Bioethics2024

    The need to understand the systems that support ethical health research has long been recognized, but there are limited descriptions of actual health research ethics (HRE) systems. Using participatory network mapping methods, we empirically defined Malaysia's HRE system. 13 Malaysian stakeholders identified 4 overarching and 25 specific HRE system functions and 35 actors internal and 3 external to the Malaysian HRE system responsible for those fu…

  • Expectations of preventative benefits and risk behaviors in a randomized trial evaluating oral HIV preexposure prophylaxis candidates

    Jane Sugarman, Brian W Weir et al.ARTICLEAIDS Care2024

    When participants enrolled in an HIV prevention trial hold a preventive misconception (PM) - expectations that experimental interventions will confer protection from HIV infection - they may engage in behaviors that increase their risk of acquiring HIV. This can raise ethical concerns about whether those enrolled in the trial understand the nature of participation and their safety. Consequently, we systematically evaluated the prevalence of PM an…

  • Prioritization of ethical concerns regarding HIV molecular epidemiology by public health practitioners and researchers

    Open AccessAnne Schuster, Anne L R Schuster et al.ARTICLEBMC Public Health2024

    The ethical issues of HIV ME vary in importance among stakeholders, reflecting different perspectives on the potential impact and usefulness of the data. Knowing these differences exist can directly inform the focus of future deliberations about the policies and practices of HIV ME in the United States

  • Recall and Appraisal of the Risks, Benefits, and Objectives of Interrupting HIV Treatment in an HIV Cure-Related Study

    Open AccessAnastasia Korolkova, Samuel Ndukwe et al.ARTICLEAIDS and Behavior2024

  • Perceptions of Molecular HIV Surveillance Among Men Who Have Sex with Men in the United States

    Open AccessMarisol Valenzuela-Lara, Thomas Sanchez et al.ARTICLEAIDS and Behavior2024

  • Developing a competency framework for health research ethics education and training

    Sean Tackett, Jane Sugarman et al.ARTICLEJournal of Medical Ethics2022

    Health research ethics (HRE) training programmes are being developed and implemented globally, often with a goal of increasing local capacity to assure ethical conduct in health-related research. Yet what it means for there to be sufficient HRE capacity is not well-defined, and there is currently no consensus on outcomes that HRE training programmes should collectively intend to achieve. Without defining the expected outcomes, meaningful evaluati…

  • Toward Meeting the Obligation of Respect for Persons in Pragmatic Clinical Trials

    Open AccessStephanie R Morain, Stephanie A Kraft et al.ARTICLEThe Hastings Center Report2022

    Research ethics oversight systems have traditionally emphasized the informed consent process as the primary means by which to demonstrate respect for prospective subjects. Yet how researchers can best fulfill the ethical obligations of respect for persons in pragmatic clinical trials (PCTs)—particularly those that may alter or waive informed consent—remains unknown. We propose eight dimensions of demonstrating respect in PCTs: (1) engaging patien…

  • Allocation of Opportunities to Participate in Clinical Trials during the Covid‐19 Pandemic and Other Public Health Emergencies

    Open AccessKayte Spector‐Bagdady, Holly Fernandez Lynch et al.ARTICLEThe Hastings Center Report2022

    Covid‐19 raised many novel ethical issues including regarding the allocation of opportunities to participate in clinical trials during a public health emergency. In this article, we explore how hospitals that have a scarcity of trial opportunities, either overall or in a specific trial, can equitably allocate those opportunities in the context of an urgent medical need with limited therapeutic interventions. We assess the three main approaches to…

  • Barriers experienced by organ procurement organizations in implementing the Hope act and HIV-positive organ donation

    Zachary Predmore, Brianna Doby et al.ARTICLEAIDS Care2022

    In the seven years since the HIV Organ Policy Equity (HOPE) Act made HIV-positive organ donation to HIV-positive recipients legally permissible in the United States, there have been fewer HIV-positive organ donations than expected. Organ procurement organizations (OPOs) play a key role in the transplant system and barriers at OPOs may be partly responsible for the relatively low number of HIV-positive donors. To understand potential OPO barriers,…

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    Open AccessRaphael J Landovitz, Deborah Donnell et al.ARTICLENew England Journal of Medicine2021

    BACKGROUND: Safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection are needed to increase the options for preventing HIV infection. METHODS: We conducted a randomized, double-blind, double-dummy, noninferiority trial to compare long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) at a dose of 600 mg, given intramuscularly every 8 …

  • Rethinking Human Embryo Research Policies

    Open AccessKirstin R W Matthews, Ana S Iltis et al.ARTICLEThe Hastings Center Report2021

    It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. The fourteen‐day limit was adopted as a compromise but subsequently has been considered an ethical line. Does it remain relevant in light of technological advances permitting embryo maturation beyond it? Should it be changed and, if…

  • Perceptions, motivations, and concerns about living organ donation among people living with HIV

    Sarah E Van Pilsum Rasmussen, Macey L Henderson et al.ARTICLEAIDS Care2018

    Recent changes to United States law now permit people living with HIV (PLWH) to donate organs to HIV-infected (HIV+) recipients under research protocols. PLWH may have unique motivations for and concerns about living donation and understanding them is critical to ensuring the integrity of this novel approach to organ transplantation. We conducted in-depth interviews with PLWH from an urban HIV clinic who had previously indicated their willingness…

  • Evidence-Based Strategies for Shortening Informed Consent Forms in Clinical Research

    Open AccessAmy Corneli, Emily Namey et al.ARTICLEJournal of Empirical Research on…2017Citada por: 2

    Long informed consent forms (ICFs) remain commonplace, yet they can negatively affect potential participants' understanding of clinical research. We aimed to build consensus among six groups of key stakeholders on advancing the use of shorter ICFs in clinical research. Partnering with the HIV Prevention Trials Network (HPTN), we used a modified Delphi process with semistructured interviews and online surveys. Concerns about redundancy of informat…

  • Comparison of Approaches for Notification and Authorization in Pragmatic Clinical Research Evaluating Commonly Used Medical Practices

    Kevin P Weinfurt, Juli M Bollinger et al.ARTICLEMedical Care2017Referências: 9

    BACKGROUND: For pragmatic clinical research comparing commonly used treatments, questions exist about if and how to notify participants about it and secure their authorization for participation. OBJECTIVE: To determine how patients react when they seek clinical care and encounter one of several different pragmatic clinical research studies. RESEARCH DESIGN: In an online survey using a between-subjects experimental design, respondents read and res…

  • Perceptions of a short-term medical programme in the Dominican Republic

    Open AccessMatthew Decamp, Samuel Enumah et al.ARTICLEGlobal Public Health2014

    Participation in short-term global health programmes for low-income countries is increasing amongst practising clinicians and trainees from high-income countries. However, few studies explicitly examine the perceptions of programme recipients. In July 2012, we conducted semi-structured interviews with a purposive sample of 47 adults receiving care from Medical Ministry International, an international non-governmental organisation providing short-…

  • An ethics curriculum for short-term global health trainees

    Open AccessMatthew Decamp, Joce Rodriguez et al.ARTICLEGlobalization and Health2013

    BACKGROUND: Interest in short-term global health training and service programs continues to grow, yet they can be associated with a variety of ethical issues for which trainees or others with limited global health experience may not be prepared to address. Therefore, there is a clear need for educational interventions concerning these ethical issues. METHODS: We developed and evaluated an introductory curriculum, "Ethical Challenges in Short-term…

  • Ethical Considerations in Determining Standard of Prevention Packages for HIV Prevention Trials

    Open AccessBridget Haire, Morenike O Folayan et al.ARTICLEDeveloping World Bioethics2013

    The successful demonstration that antiretroviral ( ARV ) drugs can be used in diverse ways to reduce HIV acquisition or transmission risks – either taken as pre‐exposure prophylaxis ( PrEP ) by those who are uninfected or as early treatment for prevention ( T4P ) by those living with HIV – expands the armamentarium of existing HIV prevention tools. These findings have implications for the design of future HIV prevention research trials. With the …

  • Guidelines for International Service Learning Programs

    Open AccessJohn A Crump, Jane Sugarman et al.ARTICLEDeveloping World Bioethics2011

  • Purpose and Benefits of Early Phase Cancer Trials

    Open AccessNorman Ka, Holly A Taylor et al.ARTICLEJournal of Empirical Research on…2008Citada por: 1Referências: 1

    CANCER PATIENTS OVERESTIMATE BENEFITS of early phase trials but studies have not reported what oncologists say to patients about trials. We audiotaped oncologists talking to cancer patients about Phase I or II trials and interviewed patients about the purpose and expected outcomes of trials presented to them. Oncologists gave mixed messages, saying Phase I trials measure safety and dosing, yet referring to trials as treatment with uncertain thera…

  • Goals of Medicine in the Course of History and Today

    Jane Sugarman, Jeremy SugarmanARTICLEBulletin of the history of medicine2007

    Reviewed by: Goals of Medicine in the Course of History and Today: A Study in the History and Philosophy of Medicine Jeremy Sugarman Kurt Fleischhauer and Göran Hermerén . Goals of Medicine in the Course of History and Today: A Study in the History and Philosophy of Medicine. Stockholm: Kungl. Vitterhets Historie och Antikvitets Akademien, 2006. 480 pp. SEK 366.00 (91-7402-353-5). This volume is the product of collaboration between a physician (K…

  • Bioethics Consultation in the Private Sector

    Baruch A Brody, Baruch Brody et al.ARTICLEGekauftes Gewissen?2007Citada por: 3

    Bioethics consultation is flourishing in the private sector. The corporate clients are aware that their work raises substantive ethical issues, and often they are concerned about how their response to these issues may affect their public image and their financial standing. Many are prepared to compensate ethics consultants at substantial rates. This is a new phenomenon for the field of bioethics. Traditionally, most requests for comment and analy…

  • Measuring Trust in Medical Researchers

    Mark A Hall, Fabian Camacho et al.ARTICLEMedical Care2006Referências: 21

    BACKGROUND: Concern is widespread that the public's and participants' trust in medical research is threatened, but few empirical measures of research trust exist. This project aims to enable more rigorous study of researcher trust by developing and testing appropriate survey measures. METHODS: Survey items were developed based on a conceptual model of the primary domains of researcher trust (safety, fidelity, honesty, global trust). Pilot testing…

  • Policy & Politics

    Jane Sugarman, Jeremy SugarmanARTICLEThe Hastings Center Report2005

    Jeremy Sugarman, Policy & Politics: Should the Gold Rule? Assessing "Equivalent Protections" for Research Participants across International Borders, The Hastings Center Report, Vol. 35, No. 5 (Sep. - Oct., 2005), pp. 12-13